152 related articles for article (PubMed ID: 38077941)
21. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
Zhou L; Du Y; Kong L; Zhang X; Chen Q
Onco Targets Ther; 2018; 11():1861-1869. PubMed ID: 29670361
[TBL] [Abstract][Full Text] [Related]
22. Construction of miRNA-mRNA network for the identification of key biological markers and their associated pathways in IgA nephropathy by employing the integrated bioinformatics analysis.
Noor F; Saleem MH; Aslam MF; Ahmad A; Aslam S
Saudi J Biol Sci; 2021 Sep; 28(9):4938-4945. PubMed ID: 34466069
[TBL] [Abstract][Full Text] [Related]
23. Identification of biomarkers related to tumorigenesis and prognosis in breast cancer.
Paizula X; Mutailipu D; Xu W; Wang H; Yi L
Gland Surg; 2022 Sep; 11(9):1472-1488. PubMed ID: 36221277
[TBL] [Abstract][Full Text] [Related]
24. Identification of Novel Genes and Associated Drugs in Cervical Cancer by Bioinformatics Methods.
Wang D; Liu Y; Cheng S; Liu G
Med Sci Monit; 2022 Apr; 28():e934799. PubMed ID: 35428744
[TBL] [Abstract][Full Text] [Related]
25. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses.
Tang D; Zhao X; Zhang L; Wang Z; Wang C
J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958
[TBL] [Abstract][Full Text] [Related]
26. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
[TBL] [Abstract][Full Text] [Related]
27. Identifying potential prognosis markers in hepatocellular carcinoma
Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
Front Genet; 2022; 13():942454. PubMed ID: 35928445
[No Abstract] [Full Text] [Related]
28. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
[No Abstract] [Full Text] [Related]
29. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
30. Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods.
Li Z; Lin Y; Cheng B; Zhang Q; Cai Y
Front Genet; 2021; 12():571231. PubMed ID: 33767726
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis and identification of key genes and signaling pathways in the occurrence and metastasis of cutaneous melanoma.
Dai H; Guo L; Lin M; Cheng Z; Li J; Tang J; Huan X; Huang Y; Xu K
PeerJ; 2020; 8():e10265. PubMed ID: 33240619
[TBL] [Abstract][Full Text] [Related]
32. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
Li L; Zhu M; Huang H; Wu J; Meng D
Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
[TBL] [Abstract][Full Text] [Related]
33. Identifying
Ding J; Liu Y; Lai Y
PeerJ; 2020; 8():e10419. PubMed ID: 33282565
[TBL] [Abstract][Full Text] [Related]
34. Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis.
Sufyan M; Ali Ashfaq U; Ahmad S; Noor F; Hamzah Saleem M; Farhan Aslam M; El-Serehy HA; Aslam S
Saudi J Biol Sci; 2021 Oct; 28(10):5518-5525. PubMed ID: 34588861
[TBL] [Abstract][Full Text] [Related]
35. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
[No Abstract] [Full Text] [Related]
36. Bioinformatic analysis of key pathways and genes shared between endometriosis and ovarian cancer.
Ni L; Chen Y; Yang J; Chen C
Arch Gynecol Obstet; 2022 May; 305(5):1329-1342. PubMed ID: 34727222
[TBL] [Abstract][Full Text] [Related]
37. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
Wu J; Lv Q; Huang H; Zhu M; Meng D
Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
[No Abstract] [Full Text] [Related]
38. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
[TBL] [Abstract][Full Text] [Related]
39. Common gene signatures and key pathways in hypopharyngeal and esophageal squamous cell carcinoma: Evidence from bioinformatic analysis.
Zhou R; Liu D; Zhu J; Zhang T
Medicine (Baltimore); 2020 Oct; 99(42):e22434. PubMed ID: 33080677
[TBL] [Abstract][Full Text] [Related]
40. Network-Based Data Analysis Reveals Ion Channel-Related Gene Features in COVID-19: A Bioinformatic Approach.
Zhang H; Feng T
Biochem Genet; 2023 Apr; 61(2):471-505. PubMed ID: 36104591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
